Compare
Elanco vs Johnson & Johnson (ELAN vs JNJ)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Elanco (ELAN) returned +19.2% and Johnson & Johnson (JNJ) +48.5%; so far this year the figures are +13.7% and +33.5%.
Johnson & Johnson is the larger company by market value, about 51.7 times the size of Elanco.
Revenue grew +12.1% at ELAN and +7.8% at JNJ over the last year.
ELAN pays no dividend. JNJ yields 1.91%.
Data as of the latest close. Not investment advice.
Relative performance
| ELAN | JNJ | |
|---|---|---|
| Price | $25.74 | $276.22 |
| 1-day | +8.70% | +1.43% |
| YTD | +13.74% | +33.47% |
| 1 year | +19.17% | +48.51% |
| 3 years | +198.26% | +85.77% |
| Market cap | $12.9B | $665.0B |
| P/E | — | 41.9 |
| P/S | 2.50 | 6.69 |
| P/B | 1.94 | 8.16 |
| Revenue growth | +12.10% | +7.80% |
| EPS growth | -600.00% | -36.40% |
| Gross margin % | 56.2 | 67.6 |
| Net margin % | -2.9 | 16.2 |
| ROE % | -2.2 | 19.7 |
| Debt / equity | 0.53 | 0.55 |
| FCF yield % | 3.2 | 3.1 |
| Dividend yield % | — | 1.91 |
| Beta | 1.32 | -0.09 |
| RSI (14) | 65.1 | 59.4 |
| Technical rating |